Note for Jan and June 2021, no surveys were entered into the system, hence the 0% scores.

Otherwise, this is a target that we generally meet.

Our key partners here, are the actual treatment drugs. The DAA drugs should literally sell themselves, but treatment access and uptake is unfortunately not this simple.

Our key partners include agencies and clinics who distribute the magazine. Their staff are important champions for Tx! Mag content. They are also very good bellwethers, keeping our editor appraised of treatment myths or misinformation that may act as a barrier or hurdle - our editor being able to build rebuttals into Tx! Mag storylines.

Researchers and health promotion workers are important allies who can advise us on treatment-related trends and issues that need addressing.

Drawing Them In workshops provide a great foundation for creating engaging content that helps promote hep C treatment.

As mentioned above, workers at agencies that distribute Tx! Mag very good bellwethers, keeping our editor appraised of treatment myths or misinformation that may act as a barrier or hurdle (our editor being able to build rebuttals into Tx! Mag storylines).

Researchers and health promotion workers are important allies who can advise us on treatment-related trends and issues that need addressing.

To remain aware of client issues around treatment access, we will continue reaching out to agencies and clinics for focus testing workshops or client/reader interviews as often as possible.

To remain fully aware of the structural and clinical issues around treatment access, we will continue to engage with the viral hepatitis workforce, especially those people working in viral hepatitis treatment.

Remaining focused on the key issues and opportunities that face our readers, we will be able to create editions of Tx! Mag that meet this performance indicator.